Skip to main content
. 2000 Feb 7;191(3):561–566. doi: 10.1084/jem.191.3.561

Figure 2.

Figure 2

Skin types I/II are more susceptible to UVR-induced immunosuppression than skin types III/IV. Analysis of individual (○, skin type I/II; •, skin type III/IV) and mean (▵, skin type I/II; ▴, skin type III/IV) slopes for CHS response shows that SSR exposure induced a highly significant dose-dependent suppression of cell-mediated immunity in all skin types (P < 0.001). CHS responses of skin types I/II were 5.3-fold lower than those of skin types III/IV throughout the dose range studied (P < 0.001; 95% CI 2.9–9.6).